Hims & Hers Health, Inc. - Common Stock (HIMS) Institutional Ownership

13F Institutional Holders and Ownership History from Q1 2020 to Q4 2025

Type / Class
Equity / Common Stock
Symbol
HIMS on NYSE
Shares outstanding
220,352,492
Price per share
$29.87
All holders as of 31 Dec 2025
Q4 2025
Total 13F shares
182,965,936
Total reported value
$5,946,032,037
% of total 13F portfolios
0.01%
Share change
-18,172,401
Value change
-$677,691,809
Number of holders
466
Price from insider filings
$29.87
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Hims & Hers Health, Inc. - Common Stock (HIMS) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Dudum Andrew 10% $1,140,783,140 23,820,905 Andrew Dudum 07 Aug 2025
BlackRock, Inc. 11% $807,569,228 23,047,067 BlackRock, Inc. 31 Mar 2025
JPMORGAN CHASE & CO 8.1% $1,009,432,170 17,796,759 JPMORGAN CHASE & CO. 30 Sep 2025
Capital World Investors 6.5% -23% $461,197,766 -$136,411,758 14,322,912 -23% Capital World Investors 31 Dec 2025

As of 31 Dec 2025, 466 institutional investors reported holding 182,965,936 shares of Hims & Hers Health, Inc. - Common Stock (HIMS). This represents 83% of the company’s total 220,352,492 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of Hims & Hers Health, Inc. - Common Stock (HIMS) together control 67% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
BlackRock, Inc. 12% 26,573,504 +5.7% 0.01% $862,841,675
VANGUARD GROUP INC 9.5% 20,925,666 +7.2% 0.01% $679,456,374
JPMORGAN CHASE & CO 8.5% 18,838,270 +5.9% 0.04% $611,678,662
Capital World Investors 6.5% 14,322,912 -24% 0.06% $465,068,856
GOLDMAN SACHS GROUP INC 4.7% 10,347,343 +12% 0.05% $335,978,228
STATE STREET CORP 3.3% 7,305,525 +1.8% 0.01% $237,210,397
GEODE CAPITAL MANAGEMENT, LLC 2.5% 5,509,764 +12% 0.01% $183,484,501
RENAISSANCE TECHNOLOGIES LLC 2.2% 4,818,009 -47% 0.24% $156,440,752
UBS Group AG 2.1% 4,549,084 +59% 0.03% $147,708,758
MORGAN STANLEY 1.8% 3,929,232 -46% 0.01% $127,582,207
FARALLON CAPITAL MANAGEMENT LLC 1.5% 3,386,986 -68% 0.63% $109,975,435
Marex Group plc 1.1% 2,419,518 +162% 0.85% $78,561,749
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 1.1% 2,398,008 +1.8% 0.01% $77,863,320
NORTHERN TRUST CORP 1.1% 2,368,029 -2% 0.01% $76,889,903
BNP PARIBAS FINANCIAL MARKETS 1% 2,215,454 0% 0.05% $71,935,791
Invesco Ltd. 0.95% 2,091,265 -50% 0.01% $67,903,374
STATE OF MICHIGAN RETIREMENT SYSTEM 0.93% 2,057,700 0% 0.32% $66,813,519
CITADEL ADVISORS LLC 0.89% 1,959,910 +1158% 0.04% $63,638,278
NORGES BANK 0.87% 1,914,177 0.01% $62,153,327
Clear Street Group Inc. 0.86% 1,904,294 +24% 0.32% $61,832,426
SUSQUEHANNA INTERNATIONAL GROUP, LLP 0.74% 1,631,839 +36% 0.07% $52,985,812
BANK OF MONTREAL /CAN/ 0.71% 1,567,834 -15% 0.02% $50,907,571
BANK OF AMERICA CORP /DE/ 0.67% 1,480,122 -18% 0% $48,059,560
JANE STREET GROUP, LLC 0.67% 1,476,960 -34% 0.06% $47,956,891
CANTOR FITZGERALD, L. P. 0.66% 1,451,446 +69% 1.4% $47,128,452

Institutional Holders of Hims & Hers Health, Inc. - Common Stock (HIMS) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 182,965,936 $5,946,032,037 -$677,691,809 $32.47 466
2025 Q3 199,877,735 $11,335,197,598 +$1,437,281,073 $56.72 508
2025 Q2 175,272,401 $8,737,551,983 +$961,576,555 $49.85 501
2025 Q1 156,499,038 $4,623,681,560 -$176,903,936 $29.55 418
2024 Q4 164,535,250 $3,980,113,570 +$662,356,870 $24.18 385
2024 Q3 137,388,700 $2,532,982,313 +$13,483,116 $18.42 302
2024 Q2 135,555,935 $2,737,194,047 +$237,895,932 $20.19 291
2024 Q1 127,014,197 $1,964,665,169 +$120,987,021 $15.47 236
2023 Q4 124,812,595 $1,110,858,696 -$20,511,047 $8.90 194
2023 Q3 119,054,225 $748,816,065 -$112,963,918 $6.29 189
2023 Q2 132,438,140 $1,244,975,489 +$139,460,952 $9.40 185
2023 Q1 119,222,566 $1,182,050,601 +$138,780,557 $9.92 185
2022 Q4 105,528,105 $676,436,778 +$198,928,135 $6.41 151
2022 Q3 94,761,647 $528,756,939 +$31,959,823 $5.58 145
2022 Q2 89,005,896 $403,186,006 +$45,235,978 $4.53 132
2022 Q1 78,422,127 $417,949,018 -$13,253,687 $5.33 127
2021 Q4 70,024,982 $458,628,840 +$14,988,392 $6.55 137
2021 Q3 42,323,200 $319,091,740 -$102,457,566 $7.54 107
2021 Q2 54,478,149 $592,933,897 +$19,733,325 $10.89 84
2021 Q1 52,489,763 $692,968,615 +$689,881,615 $13.23 80
2020 Q4 186,615 $2,725,000 +$2,725,000 $14.60 1
2020 Q3 0 $0 -$53,000 $29.87 0
2020 Q1 4,000 $53,000 $13.25 1